Antique Stock Broking is bullish on SKS Microfinance and has recommended buy rating on the stock with a target price of Rs 570 , in its research report dated September 02, 2015.
Sun Pharma was at lifetime high yesterday at Rs 854. It has received final approval for Novartis's Reclast/Aclasta, which is used in the treatment of osteoporosis.